The results suggest AR-V7-postive patients should be treated with chemotherapy over AR-directed hormonal therapies to which they are highly resistant.

The company is offering about 3.6 million shares of its common stock, and warrants to purchase 715,000 shares of its stock.

Bio-Rad reported $598.2 million in revenues for the quarter, down from $602.6 million a year ago but surpassing the average analysts' estimate of $593.4 million.

The firm has also created a qPCR-based Staphylococcus aureus resistance gene assay with a run time of three minutes.

Available in March, the PCR-based FilmArray 2.0 platform has higher throughput and takes up a smaller footprint.

Multiple fluorophore detector system
Self-contained biological analysis
Oligonucleotides and methods for detecting KRAS and PIK3CA mutations
Methods of isothermal amplification using blocked primers
Primers for detecting Plasmodium
Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the MAGE-A3-marker